Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin

International Journal of Neuropsychopharmacology

Volumn 17, Issue 9, 2014, Pages 1357-1365

  Gottas A ^a   Boix, F ^a   Oiestad, E L ^a   Vindenes, V ^a   Morland, J ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

dopamine; Drug abuse; heroin; metabolite kinetics; microdialysis

Indexed keywords

DIAMORPHINE; DOPAMINE; MORPHINE; MORPHINE 6 ACETATE; 6-O-MONOACETYLMORPHINE; MORPHINE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRACELLULAR FLUID; MALE; MAXIMUM PLASMA CONCENTRATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; AREA UNDER THE CURVE; CORPUS STRIATUM; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT; TIME; WAKEFULNESS;

ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR FLUID; HEROIN; INJECTIONS, INTRAVENOUS; MALE; MICRODIALYSIS; MORPHINE; MORPHINE DERIVATIVES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WAKEFULNESS;

EID: 84905044338     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000169     Document Type: Article

References (40)

1. Aasmundstad TA, Morland J, Paulsen RE (1995) Distribution of morphine 6-glucuronide and morphine across the blood- brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 275:435-441.
2. Andersen JM, Ripel A, Boix F, Normann PT, Morland J (2009) Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a pro-drug for the mediator, 6-monoacetylmorphine, in vivo. J Pharmacol Exp Ther 331:153-161.
3. Balster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:119-129.
4. Boix F, Andersen JM, Mørland J (2013) Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice. Addict Biol 18:1-7.
5. Cadoni C, Di Chiara G (1999) Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neurosc 90:447-455.
6. Church WH, Justice JB, Byrd LD (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur J Pharmacol 139:345-348.
7. Dacher M, Nugent FS (2011) Opiates and plasticity. Neuropharmacology 61:1088-1096.
8. Di Chiara G, Imperato A (1988a) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
9. Di Chiara G, Imperato A (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080.
10. Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154:261-274.
11. Gianutsos G, Cohen SD, Carlson G, Heyman R, Salva P, Morrow G, Hite GJ (1986) Alteration of in vivo and in vitro effects of heroin by esterase inhibition. Toxicol Appl Pharmacol 82:14-18.
12. Glatting G, Kletting P, Reske SN, Hohl K, Ring C (2007) Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys 34:4285-4292.
13. Gottås A, Oiestad EL, Boix F, Ripel A, Thaulow CH, Pettersen BS, Vindenes V, Morland J (2012) Simultaneous measurement of heroin and its metabolites in brain extracellular fluid by microdialysis and ultra performance liquid chromatography tandem mass spectrometry. J Pharmacol Toxicol Methods 66:14-21.
14. Gottås A, Øiestad EL, Boix F, Vindenes V, Ripel Å, Thaulow CH, Mørland J (2013) Levels of heroin and its metabolites in blood and brain extracellular fluid after intravenous heroin administration to freely moving rats. Br J Pharmacol 170:546-556.
15. Hemby SE, Martin TJ, Co C, Dworkin SI, Smith JE (1995) The effects of intravenous heroin administration on extracellular nucleus-Accumbens dopamine concentrations as determined by in-vivo microdialysis. J Pharmacol Exp Ther 273:591-598.
16. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Science 33 (Suppl. 1):773-776.
17. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
18. Karinen R, Andersen JM, Ripel A, Hasvold I, Hopen AB, Morland J, Christophersen AS (2009) Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography-tandem mass spectrometry. J Anal Toxicol 33:345-350.
19. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858.
20. Kiyatkin EA, Wise RA, Gratton A (1993) Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. Synapse 14:60-72.
21. Leone P, Pocock D, Wise RA (1991) Morphine-Dopamine interaction - ventral tegmental morphine increases nucleus-accumbens dopamine release. Pharmacol Biochem Behav 39:469-472.
22. Letrent SP (1999) Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab Disposition 27:827-834.
23. Lockridge O, Mottershaw-Jackson N, Eckerson HW, La Du BN (1980) Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J Pharmacol Exp Ther 215:1-8.
24. Ludden TM, Beal SL, Sheiner LB (1994) Comparison of the akaike information criterion, the schwarz criterion and the F-test as guides to model selection. J Pharmacokinet Biopharm 22:431-445.
25. Marinelli M, Barrot M, Simon H, Oberlander C, Dekeyne A, Moal ML, Piazza PV (1998) Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci 10:3269-3275.
26. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449.
27. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press
28. Pleuvry BJ (2005) Hysteresis in drug response. Anaesth Intensive Care Med 6:286-287.
29. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308.
30. Rook EJ, Huitema AD, van den Brink W, Van Ree JM, Beijnen JH (2006a) Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol 1:109-118.
31. Rook EJ, Van Ree JM, van den Brink W, Hillebrand MJX, Huitema ADR, Hendriks VM, Beijnen JH (2006b) Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol 98:86-96.
32. Samaha AN, Robinson TE (2005) Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 26:82-87.
33. Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR (2001) [mu] Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol 62:447-455.
34. Tunblad K, Jonsson EN, Hammarlund-Udenaes M (2003) Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm Res 20:618-623.
35. Vindenes V, Pettersen BS, Gottas A, Christiansen NL, Boix F, Morland J (2009) Different effects on dopamine release in nucleus accumbens in mice by the morphine metabolites morphine-6-Glucuronide and morphine-3-Glucuronide. Basic Clin Pharmacol Toxicol 105:357-360.
36. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463.
37. Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:557-569.
38. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575-1579.
39. Way EL, Young JM, Kemp JW (1965) Metabolism of heroin and its pharmacologic implications. Bull Narc 19:25-33.
40. Wise RA, Leone P, Rivest R, Leeb K (1995) Elevations of nucleus-Accumbens dopamine and dopac levels during intravenous heroin self-administration. Synapse 21:140-148.